First time using JMP Clinical - Aiming to use it for data review
Shionogi & Co., Ltd. Analysis Center, Data Management Division Akari Kamiya Shionogi & Co., Ltd. Analysis Center, Data Management Division Dai Kanba
JMP Clinical is a useful tool for reviewing data. However, it is difficult to use it. To begin with, it is difficult to read the data. Even SDTM, which complies with the CDISC standard, may not be readable due to its unique requirements for JMP Clinical. I think this is an issue that many people who use JMP Clinical run into. If you can overcome this hurdle, you can use it as a tool to find irregular data or confirm safety during the trial. At the end of the trial, you can check the clinical trial data from the same perspective as the PMDA/FDA, who will review the data with JMP Clinical. If you can get along well with JMP Clinical, you will gain a lot of knowledge. In Japan, there are few reports of the use of JMP Clinical. In this presentation, I would like to introduce some cases and exchange opinions with the participants. As a result, I hope to use JMP Clinical more effectively.
